ARTICLE | Clinical News
Xarelto rivaroxaban regulatory update
January 23, 2012 8:00 AM UTC
Bayer said Japan's Ministry of Health, Labor and Welfare (MHLW) approved Xarelto rivaroxaban to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). Xarelto is ...